Company Filing History:
Years Active: 2016-2018
Title: The Innovations of Andrew K Koski
Introduction
Andrew K Koski is a notable inventor based in Hoffman Estates, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized dosage forms. With a total of 2 patents, his work focuses on innovative methods to treat various medical conditions.
Latest Patents
Andrew's latest patents include advancements in stabilized pharmaceutical dosage forms comprising atrasentan. The first patent outlines methods for using these dosage forms to treat type 2 diabetes, microalbuminuria, or macroalbuminuria. The second patent expands on this by detailing methods for treating nephropathy and chronic kidney disease, along with the preparation of these pharmaceutical forms. Both patents emphasize the importance of stabilized formulations in enhancing therapeutic efficacy.
Career Highlights
Andrew K Koski is currently employed at AbbVie Inc., a leading global biopharmaceutical company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for complex health issues. His contributions have been instrumental in advancing treatment options for patients.
Collaborations
Andrew has collaborated with notable colleagues such as Ye Huang and Katherine E Peterson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Andrew K Koski's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and contributions to AbbVie Inc. highlight his commitment to improving patient outcomes through advanced therapeutic solutions.